OCA
MREO

Octagon Capital Advisors’s Mereo BioPharma MREO Stock Holding History

Octagon Capital Advisors’s Portfolio MREO Stock Details MREO Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$750K Hold
2022
Q3 		$861K Hold
2022
Q2 		$1.12M Buy